ImmuCell Corp Files 8-K on Financials
Ticker: ICCC · Form: 8-K · Filed: Feb 25, 2025 · CIK: 811641
| Field | Detail |
|---|---|
| Company | Immucell Corp /De/ (ICCC) |
| Form Type | 8-K |
| Filed Date | Feb 25, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, results-of-operations, exhibits
TL;DR
ImmuCell filed its 8-K, check it for the latest financial and operational updates.
AI Summary
ImmuCell Corporation filed an 8-K on February 25, 2025, reporting on its financial condition and results of operations. The filing details the company's financial statements and exhibits, providing an update on its business performance. Specific financial figures and operational details are contained within the full report.
Why It Matters
This 8-K filing provides investors with crucial updates on ImmuCell Corporation's financial health and operational results, impacting investment decisions.
Risk Assessment
Risk Level: medium — 8-K filings can contain significant financial and operational information that may impact a company's stock price, requiring careful review.
Key Players & Entities
- ImmuCell Corporation (company) — Registrant
- February 25, 2025 (date) — Date of Report
- Portland, Maine (location) — Principal Executive Offices
- 207-878-2770 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this Form 8-K filing for ImmuCell Corporation?
The primary purpose of this Form 8-K filing is to report on ImmuCell Corporation's Results of Operations and Financial Condition, including its Financial Statements and Exhibits.
On what date was this 8-K filing submitted?
This 8-K filing was submitted on February 25, 2025.
What is ImmuCell Corporation's principal executive office address?
ImmuCell Corporation's principal executive office is located at 56 Evergreen Drive, Portland, Maine 04103.
What is the telephone number for ImmuCell Corporation?
ImmuCell Corporation's telephone number, including area code, is 207-878-2770.
What is the SIC code for ImmuCell Corporation?
The Standard Industrial Classification (SIC) code for ImmuCell Corporation is 2835, which corresponds to 'IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES'.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 25, 2025 regarding IMMUCELL CORP /DE/ (ICCC).